BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu C, Rao D, Zhu H, Liu Q, Huang W, Zhang L, Liang H, Song J, Ding Z. TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27. Biomed Res Int 2021;2021:4708439. [PMID: 34423034 DOI: 10.1155/2021/4708439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Chandan G, Saini AK, Kumari R, Chakrabarti S, Mittal A, Sharma AK, Saini RV. The exploitation of enzyme-based cancer immunotherapy. Hum Cell 2023;36:98-120. [PMID: 36334180 DOI: 10.1007/s13577-022-00821-2] [Reference Citation Analysis]
2 Cui J, Tian Y, Liu T, Lin X, Li L, Li Z, Shen L, Trivanovic D. Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/5447017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]